Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border

Daiana Mir, Natalia Rego, Paola Cristina Resende, Fernando López-Tort, Tamara Fernandez-Calero, Verónica Noya, Mariana Brandes, Tania Possi, Mailen Arleo, Natalia Reyes, Matías Victoria, Andrés Lizasoain, Matías Castells, Leticia Maya, Matías Salvo, Tatiana Schäffer Gregianini, Marilda Tereza Mar da Rosa, Letícia Garay Martins, Cecilia Alonso, Yasser Vega, Cecilia Salazar, Ignacio Ferrés, Pablo Smircich, Jose Sotelo, Rafael Sebastián Fort, Cecilia Mathó, Ighor Arantes, Luciana Appolinario, Ana Carolina Mendonça, María José Benitez-Galeano, Martín Graña, Camila Simoes, Fernando Motta, Marilda Mendonça Siqueira, Gonzalo Bello, Rodney Colina, Lucía Spangenberg
doi: https://doi.org/10.1101/2021.01.06.20249026
Daiana Mir
1Unidad de Genómica y Bioinformática. Departamento de Ciencias Biológicas. Centro Universitario Regional del Litoral Norte. Universidad de la República, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Rego
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Cristina Resende
3Laboratorio de Virus Respiratorios e Sarampo, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando López-Tort
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamara Fernandez-Calero
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
14Departamento de Ciencias Exactas y Naturales, Universidad Católica del Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verónica Noya
5Laboratorio de Biología Molecular, Sanatorio Americano, Montevideo, Uruguay
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Brandes
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tania Possi
5Laboratorio de Biología Molecular, Sanatorio Americano, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mailen Arleo
5Laboratorio de Biología Molecular, Sanatorio Americano, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Reyes
5Laboratorio de Biología Molecular, Sanatorio Americano, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matías Victoria
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrés Lizasoain
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matías Castells
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leticia Maya
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matías Salvo
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Schäffer Gregianini
6Laboratório Central, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS), Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilda Tereza Mar da Rosa
6Laboratório Central, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS), Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Letícia Garay Martins
7Centro Estadual de Vigilância em Saúde da Secretaria do Estado do Rio Grande do Sul, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Alonso
8CENUR Este-Sede Rocha-UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser Vega
9Laboratorio DILAVE/MGAP-INIA-UdelaR-Tacuarembó
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Salazar
10Laboratorio de Genómica microbiana, Institut Pasteur de Montevideo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignacio Ferrés
10Laboratorio de Genómica microbiana, Institut Pasteur de Montevideo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Smircich
11Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC. Laboratorio de Interacciones Moleculares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose Sotelo
12Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC. Sección Biología Celular, Depto. de Biología Molecular y Celular, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael Sebastián Fort
11Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC. Laboratorio de Interacciones Moleculares, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Mathó
12Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC. Sección Biología Celular, Depto. de Biología Molecular y Celular, Facultad de Ciencias, UdelaR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ighor Arantes
13Laboratorio de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciana Appolinario
3Laboratorio de Virus Respiratorios e Sarampo, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Carolina Mendonça
3Laboratorio de Virus Respiratorios e Sarampo, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María José Benitez-Galeano
1Unidad de Genómica y Bioinformática. Departamento de Ciencias Biológicas. Centro Universitario Regional del Litoral Norte. Universidad de la República, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martín Graña
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camila Simoes
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Motta
3Laboratorio de Virus Respiratorios e Sarampo, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilda Mendonça Siqueira
3Laboratorio de Virus Respiratorios e Sarampo, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonzalo Bello
13Laboratorio de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz – Fiocruz, Río de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lucia{at}pasteur.edu.uy
Rodney Colina
4Laboratorio de Virología Molecular. CENUR Litoral Norte – UdelaR, Salto, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lucia{at}pasteur.edu.uy
Lucía Spangenberg
2Unidad de Bioinformática, Institut Pasteur de Montevideo, Montevideo, Uruguay
15Departamento de Informática y Ciencias de la Computación, Universidad Católica del Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lucia{at}pasteur.edu.uy
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Background Uruguay is one of the few countries in the Americas that successfully contained the COVID-19 epidemic during the first half of 2020. Nevertheless, the intensive human mobility across the dry border with Brazil is a major challenge for public health authorities. We aimed to investigate the origin of SARS-CoV-2 strains detected in Uruguayan localities bordering Brazil as well as to measure the viral flux across this ∼1,100 km uninterrupted dry frontier.

Methods Using complete SARS-CoV-2 genomes from the Uruguayan-Brazilian bordering region and phylogeographic analyses, we inferred the virus dissemination frequency between Brazil and Uruguay and characterized local outbreak dynamics during the first months (May-July) of the pandemic.

Findings Phylogenetic analyses revealed multiple introductions of SARS-CoV-2 Brazilian lineages B.1.1.28 and B.1.1.33 into Uruguayan localities at the bordering region. The most probable sources of viral strains introduced to Uruguay were the Southeast Brazilian region and the state of Rio Grande do Sul. Some of the viral strains introduced in Uruguayan border localities between early May and mid-July were able to locally spread and originated the first outbreaks detected outside the metropolitan region. The viral lineages responsible for Uruguayan suburban outbreaks were defined by a set of between four and 11 mutations (synonymous and non-synonymous) respect to the ancestral B.1.1.28 and B.1.1.33 viruses that arose in Brazil, supporting the notion of a rapid genetic differentiation between SARS-CoV-2 subpopulations spreading in South America.

Interpretation Although Uruguayan borders have remained essentially closed to non-Uruguayan citizens, the inevitable flow of people across the dry border with Brazil allowed the repeated entry of the virus into Uruguay and the subsequent emergence of local outbreaks in Uruguayan border localities. Implementation of coordinated bi-national surveillance systems are crucial to achieve an efficient control of the SARS-CoV-2 spread across this kind of highly permeable borderland regions around the world.

Evidence before this study Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causative agent of coronavirus disease 19 (COVID-19), was first detected in South America on February 26, 2020, it has rapidly spread through the region, causing nearly 350,000 deaths by December, 2020. In contrast to most American countries, Uruguay avoided an early exponential growth of SARS-CoV-2 cases and during the first six months of the pandemic it registered the lowest incidence of SARS-CoV-2 cases and deaths among South American countries. The intensive cross-border human mobility through the ∼1,100 km uninterrupted dry frontier between Uruguay and Brazil, might poses a major challenge for long-term control of the epidemic in Uruguay. Previous genomic studies conducted in Uruguay have analyzed sequences mostly sampled at the capital city, Montevideo, and detected prevalent SARS-CoV-2 lineages different from those described in Brazil, thus finding no evidence of frequent viral exchanges between these countries.

Added value of this study Here we present the first genomic study of SARS-CoV-2 strains detected in different Uruguayan and Brazilian localities along the bordering region. The samples analyzed include 30% (n = 59) of all laboratory confirmed SARS-CoV-2 cases from Uruguayan departments at the Brazilian border between March and July, 2020, as well as 68 SARS-CoV-2 sequences from individuals diagnosed in the southernmost Brazilian state of Rio Grande do Sul between March and August, 2020. We demonstrate that SARS-CoV-2 viral lineages that widely spread in the Southeastern Brazilian region (B.1.1.28 and B.1.1.33) were also responsible for most viral infections in Rio Grande do Sul and neighboring Uruguayan localities. We further uncover that major outbreaks detected in Uruguayan localities bordering Brazil in May and June, 2020, were originated from two independent introduction events of the Brazilian SARS-CoV-2 lineage B.1.1.33, unlike previous outbreaks in the Uruguayan metropolitan region that were seeded by European SARS-CoV-2 lineages.

Implications of all the available evidence Our findings confirm that although Uruguayan borders have remained essentially closed to non-Uruguayan citizens, dissemination of SARS-CoV-2 across the Uruguayan-Brazilian frontier was not fully suppressed and had the potential to ignite local transmission chains in Uruguay. These findings also highlight the relevance of implementing bi-national public health cooperation workforces combining epidemiologic and genomic data to monitor the viral spread throughout this kind of highly permeable dry frontiers around the world.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Brazil: Funding support from CGLab/MoH (General Laboratories Coordination of Brazilian Ministry of Health), CVSLR/FIOCRUZ (Coordination of Health Surveillance and Reference Laboratories of Oswaldo Cruz Foundation), CNPq COVID-19 MCTI 402457/2020-0 and INOVA VPPCB-005-FIO437 20-2. Uruguay: This work was funded by the Manuel Perez Foundation that nucleated COVID19 donation fonds in the context of the project 'Vigilancia epidemiológica del COVID-19 en las fronteras uruguayas y análisis de su transmisión en el interior del país'

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved in Uruguay by the Ethics Committees of the Sanatorio Americano (CEI-SASA). Board members were: Dr. Oscar Cluzet, Dr. Enrique Mendez, Dr. Alberto Aliaga and Mr. Richard Riera. This study was approved in Brazil by following ethics committees: FIOCRUZ-IOC Ethics Committee: 68118417.6.0000.5248, and Brazilian Ministry of Health SISGEN: A1767C3.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data was uploaded to GISAID

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border
Daiana Mir, Natalia Rego, Paola Cristina Resende, Fernando López-Tort, Tamara Fernandez-Calero, Verónica Noya, Mariana Brandes, Tania Possi, Mailen Arleo, Natalia Reyes, Matías Victoria, Andrés Lizasoain, Matías Castells, Leticia Maya, Matías Salvo, Tatiana Schäffer Gregianini, Marilda Tereza Mar da Rosa, Letícia Garay Martins, Cecilia Alonso, Yasser Vega, Cecilia Salazar, Ignacio Ferrés, Pablo Smircich, Jose Sotelo, Rafael Sebastián Fort, Cecilia Mathó, Ighor Arantes, Luciana Appolinario, Ana Carolina Mendonça, María José Benitez-Galeano, Martín Graña, Camila Simoes, Fernando Motta, Marilda Mendonça Siqueira, Gonzalo Bello, Rodney Colina, Lucía Spangenberg
medRxiv 2021.01.06.20249026; doi: https://doi.org/10.1101/2021.01.06.20249026
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border
Daiana Mir, Natalia Rego, Paola Cristina Resende, Fernando López-Tort, Tamara Fernandez-Calero, Verónica Noya, Mariana Brandes, Tania Possi, Mailen Arleo, Natalia Reyes, Matías Victoria, Andrés Lizasoain, Matías Castells, Leticia Maya, Matías Salvo, Tatiana Schäffer Gregianini, Marilda Tereza Mar da Rosa, Letícia Garay Martins, Cecilia Alonso, Yasser Vega, Cecilia Salazar, Ignacio Ferrés, Pablo Smircich, Jose Sotelo, Rafael Sebastián Fort, Cecilia Mathó, Ighor Arantes, Luciana Appolinario, Ana Carolina Mendonça, María José Benitez-Galeano, Martín Graña, Camila Simoes, Fernando Motta, Marilda Mendonça Siqueira, Gonzalo Bello, Rodney Colina, Lucía Spangenberg
medRxiv 2021.01.06.20249026; doi: https://doi.org/10.1101/2021.01.06.20249026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)